Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 7Other hematologic neoplasm 3Lymphoid 3Gastrointestinal 2CNS 2Sarcoma 1Plasma cell 1Genitourinary 1

Conditions

Hepatocellular Carcinoma With Portal Vein Thrombosis 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carvedilol × Gastrointestinal × Clear all
NCT06836778 2025-02-20

Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal Varices

Institute of Liver and Biliary Sciences, India

Phase NA Not yet recruiting
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01659346 2017-11-17

Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.

Institute of Liver and Biliary Sciences, India

Phase NA Withdrawn
Gastrointestinal

Hepatocellular Carcinoma With Portal Vein Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡